29 November 2022

The Lung Cancer Policy Network is a global, multidisciplinary network of experts from across the lung cancer community, all dedicated to improving survival from lung cancer. This Lung Cancer Awareness Month, we advocate for earlier lung cancer detection, through targeted screening, as a matter of urgency.

Lung cancer is a significant healthcare challenge, accounting for about one fifth of all cancer-related deaths globally1. However, there is a real opportunity to increase the early detection of lung cancer through low-dose CT screening, and, in doing so, save lives.

There is substantial, high-quality evidence to support the implementation of targeted lung cancer screening. What is needed, and what the Lung Cancer Policy Network hopes to drive, is the political will to turn this evidence into action.

Lung Cancer Policy Network members representing a range of locations and areas of expertise feature in this video. As well as highlighting opportunities to identify the people who could most benefit from lung cancer screening, they emphasise the importance of collaboration.

The case is clear that lung cancer screening can save lives. Let’s start by ensuring that evidence leads to action.

Network members featured:

  • Andrea Borondy Kitts (Rescue Lung Society, US)
  • David Baldwin (University of Nottingham, UK)
  • Stephen Lam (University of British Columbia, Canada)
  • Mariusz Adamek (Medical University of Silesia and Medical University of Gdańsk, Poland)
  • Ebba Hallersjö Hult (Vision Zero Cancer, Sweden)
Share

Recent news

News

Network produces recommendations for lung cancer screening in Asia Pacific

Network produces recommendations for lung cancer screening in Asia Pacific

The Lung Cancer Policy Network recently hosted a collaborative workshop with the Asia Pacific Coalition Against Lung Cancer during the Asia Conference on Lung Cancer.

Blog

2024 reflections: a year of progress across the global lung cancer community

2024 reflections: a year of progress across the global lung cancer community

More people have access to LDCT screening than ever before. This year, four more countries have made a formal commitment to implement LDCT screening for lung cancer, and several implementation studies are under way.

Case study

Building evidence to inform future roll-out of lung cancer screening in Estonia

Building evidence to inform future roll-out of lung cancer screening in Estonia

We examine the key evidence used to inform the development of a national screening programme for lung cancer in Estonia from 2021 to date.

References

  1. Ferlay J, Ervik M, Lam F, et al. 2020. GLOBOCAN 2020 cancer fact sheet: all cancers. Lyon: Global Cancer Observatory